ImageneBio, Inc. Revenue From Contract With Customer Excluding Assessed Tax

• ImageneBio, Inc. showed a decrease of -77.1% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
• This data is from ImageneBio, Inc.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
• XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 6 years of available data (2020 to 2025), ImageneBio, Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has declined by 91.3%.
• Historical annual values: Fiscal year 2025: $800.0 thousand | Fiscal year 2024: $3.50 million | Fiscal year 2023: $9.16 million | Fiscal year 2022: $15.62 million | Fiscal year 2021: $30.99 million | Fiscal year 2020: $9.19 million.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026